Skip to content
Search

Latest Stories

Submit Guest Post

Flight attendants more likely to get cancer

People working in some professions are more likely to develop health problems such as cancer, according to a new study.

For instance, flight attendants are more likely to develop skin and breast cancer than the general public. It is believed that cosmic radiations and the ultra-violet rays that flight attendants are constantly subjected to pose serious health risks.


The study found that female flight attendants had a higher prevalence of every cancer, especially breast cancer and skin cancer. This finding is surprising as flight attendants normally lead a healthy lifestyle. They often avoid many other common risk factors for cancer such as smoking and obesity.

"Our findings of higher rates of several cancers among flight attendants is striking given the low rates of overweight and smoking in our study population, which highlights the question of what can be done to minimize the adverse exposures and cancers common among cabin crew," said Irina Mordukhovich, lead author and a research associate at Harvard University’s T.H. Chan School of Public Health.

"Something that somewhat surprised us, to some extent, was that we also saw a higher instance of breast cancer in women with three or more children," said Mordukhovich. Typically, the risk of breast cancer decreases in women with more children.

"Women with three or more children are already probably not getting enough sleep," Mordukhovich said. "Combine that with this disruption from the job, especially for those who fly internationally, this may be an indication that the circadian rhythm disruption is having an impact."

Sadly, flight attendants aren't the only ones prone to high cancer risks. Those in the farming and construction sectors are also prone to skin cancer due to too much exposure to ultra violet radiation from the sun. Farmers also expose themselves to harmful agricultural chemicals, which in turn increases cancer risk.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less